MUMBAI, May 14 (Reuters) - Shares of India's Matrix Laboratories rose as much as 15 percent to a three-month high on news that Mylan Laboratories Inc. , which controls the firm, will buy the generics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results